Difference in the effects of switching from Candesartan to Olmesartan or Telmisartan to Olmesartan in hypertensive patients with type 2 diabetes: the COTO study
Hiroyuki Daikuhara, Kensaku Fukunaga, Tomie Ohshima Department of Internal Medicine, Sakaide City Hospital, Kagawa, Japan Purpose: This open-label controlled study compared the therapeutic efficacy of three representative angiotensin II receptor blockers (ARBs) in hypertensive patients with type 2...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-02-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/difference-in-the-effects-of-switching-from-candesartan-to-olmesartan--peer-reviewed-article-DDDT |